Human Papillomavirus Vaccines Market Size, Share, Growth | Global Industry Research Report, 2019-2026

SKU ID :FBUIN-15633518 | Published Date: 01-Jan-2020 | No. of pages: 132
1. Introduction 1. Research Scope 2. Market Segmentation 3. Research Methodology 4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 1. Market Drivers 2. Market Restraints 3. Market Opportunities 4. Key Insights 1. Pipeline Analysis 2. Technological Advancements in the Human Papillomavirus Vaccines Market 3. Regulatory Scenario - For Key Countries, 2018 4. Prevalence of Cervical Cancer - For Key Countries, 2018 5. Key Industry Developments - Mergers, Acquisitions, and Partnerships 5. Global Human Papillomavirus Vaccines Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Type 1. Bivalent 2. Polyvalent 3. Market Analysis, Insights and Forecast – By Disease Indication 1. HPV Associated Cancer 2. Genital Warts 4. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital & Retail Pharmacies 2. Government Suppliers 3. Others 5. Market Analysis, Insights and Forecast – By Geography 1. North America 2. Europe 3. Asia pacific 4. Latin America 5. Middle East & Africa 6. North America Human Papillomavirus Vaccines Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Type 1. Bivalent 2. Polyvalent 3. Market Analysis, Insights and Forecast – By Disease Indication 1. HPV Associated Cancer 2. Genital Warts 4. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital & Retail Pharmacies 2. Government Suppliers 3. Others 5. Market Analysis, Insights and Forecast – By Country 1. U.S. 2. Canada 7. Europe Human Papillomavirus Vaccines Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Type 1. Bivalent 2. Polyvalent 3. Market Analysis, Insights and Forecast – By Disease Indication 1. HPV Associated Cancer 2. Genital Warts 4. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital & Retail Pharmacies 2. Government Suppliers 3. Others 5. Market Analysis, Insights and Forecast – By Country/Sub-region 1. U.K. 2. Germany 3. France 4. Spain 5. Italy 6. Scandinavia 7. Rest of Europe 8. Asia Pacific Human Papillomavirus Vaccines Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Type 1. Bivalent 2. Polyvalent 3. Market Analysis, Insights and Forecast – By Disease Indication 1. HPV Associated Cancer 2. Genital Warts 4. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital & Retail Pharmacies 2. Government Suppliers 3. Others 5. Market Analysis, Insights and Forecast – By Country/Sub-region 1. Japan 2. China 3. India 4. Australia 5. Southeast Asia 6. Rest of Asia Pacific 9. Latin America Human Papillomavirus Vaccines Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Type 1. Bivalent 2. Polyvalent 3. Market Analysis, Insights and Forecast – By Disease Indication 1. HPV Associated Cancer 2. Genital Warts 4. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital & Retail Pharmacies 2. Government Suppliers 3. Others 5. Market Analysis, Insights and Forecast – By Country/Sub-region 1. Brazil 2. Mexico 3. Rest of Latin America 10. Middle East & Africa Human Papillomavirus Vaccines Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Type 1. Bivalent 2. Polyvalent 3. Market Analysis, Insights and Forecast – By Disease Indication 1. HPV Associated Cancer 2. Genital Warts 4. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital & Retail Pharmacies 2. Government Suppliers 3. Others 5. Market Analysis, Insights and Forecast – By Country/Sub-region 1. GCC Countries 2. South Africa 3. Rest of Middle East & Africa 11. Competitive Analysis 1. Key Industry Developments 2. Global Market Share Analysis (2018) 3. Competition Dashboard 4. Comparative Analysis – Major Players 5. Company Profiles 1. GlaxoSmithKline plc. 1. Overview, 2. Products & Services, 3. SWOT analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 2. Merck & Co., Inc 1. Overview, 2. Products & Services, 3. SWOT analysis, 4. Recent Developments, 5. Strategies, 6. Financials (Based on Availability) 12. Strategic Recommendations LIST OF TABLES Table 1: Global Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Type, 2015–2026 Table 2: Global Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015–2026 Table 3: Global Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026 Table 4: Global Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Region, 2015-2026 Table 5: North America Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Type, 2015-2026 Table 6: North America Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026 Table 7: North America Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026 Table 8: North America Human Papillomavirus Market Revenue (US$ Mn) Forecast, By Country, 2015-2026 Table 9: Europe Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Type, 2015-2026 Table 10: Europe Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026 Table 11: Europe Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026 Table 12: Europe Human Papillomavirus Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026 Table 13: Asia Pacific Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Type, 2015-2026 Table 14: Asia Pacific Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026 Table 15: Asia Pacific Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026 Table 16: Asia Pacific Human Papillomavirus Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026 Table 17: Latin America Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Type, 2015-2026 Table 18: Latin America Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026 Table 19: Latin America Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026 Table 20: Latin America Human Papillomavirus Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026 Table 21: Middle East & Africa Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Type, 2015-2026 Table 22: Middle East & Africa Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026 Table 23: Middle East & Africa Human Papillomavirus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026 Table 24: Middle East & Africa Human Papillomavirus Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026 LIST OF FIGURES Figure 1: Global Human Papillomavirus Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026 Figure 2: Global Human Papillomavirus Market Value Share (%), by Type, 2018 & 2026 Figure 3: Global Human Papillomavirus Market Forecast (US$ Mn), by Bivalent, 2015-2026 Figure 4: Global Human Papillomavirus Market Forecast (US$ Mn), by Polyvalent, 2015-2026 Figure 5: Global Human Papillomavirus Market Value Share (%), by Disease Indication, 2018 & 2026 Figure 6: Global Human Papillomavirus Market Forecast (US$ Mn), by HPV Associated Cancer, 2015-2026 Figure 7: Global Human Papillomavirus Market Forecast (US$ Mn), by Genital Warts, 2015-2026 Figure 8: Global Human Papillomavirus Market Value Share (%), by Distribution Channel, 2018 & 2026 Figure 9: Global Human Papillomavirus Market Forecast (US$ Mn), by Hospital & Retail Pharmacies, 2015-2026 Figure 10: Global Human Papillomavirus Market Forecast (US$ Mn), by Government Suppliers, 2015-2026 Figure 11: Global Human Papillomavirus Market Forecast (US$ Mn), by Others, 2015-2026 Figure 12: Global Human Papillomavirus Market Value (US$ Mn), by Region, 2018 & 2026 Figure 13: North America Human Papillomavirus Market Value (US$ Mn), by Type, 2018 & 2026 Figure 14: North America Human Papillomavirus Market Value Share (%), by Type, 2018 Figure 15: North America Human Papillomavirus Market Value (US$ Mn), by Disease Indication, 2018 & 2026 Figure 16: North America Human Papillomavirus Market Value Share (%), by Disease Indication, 2018 Figure 17: North America Human Papillomavirus Market Value (US$ Mn), by Distribution Channel, 2018 & 2026 Figure 18: North America Human Papillomavirus Market Value Share (%), by Distribution Channel, 2018 Figure 19: North America Human Papillomavirus Market Value (US$ Mn), By Country, 2018 & 2026 Figure 20: North America Human Papillomavirus Market Value Share (%), By Country, 2018 Figure 21: Europe Human Papillomavirus Market Value (US$ Mn), by Type, 2018 & 2026 Figure 22: Europe Human Papillomavirus Market Value Share (%), by Type, 2018 Figure 23: Europe Human Papillomavirus Market Value (US$ Mn), by Disease Indication, 2018 & 2026 Figure 24: Europe Human Papillomavirus Market Value Share (%), by Disease Indication, 2018 Figure 25: Europe Human Papillomavirus Market Value (US$ Mn), by Distribution Channel, 2018 & 2026 Figure 26: Europe Human Papillomavirus Market Value Share (%), by Distribution Channel, 2018 Figure 27: Europe Human Papillomavirus Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026 Figure 28: Europe Human Papillomavirus Market Value Share (%), By Country/ Sub-region, 2018 Figure 29: Asia Pacific Human Papillomavirus Market Value (US$ Mn), by Type, 2018 & 2026 Figure 30: Asia Pacific Human Papillomavirus Market Value Share (%), by Type, 2018 Figure 31: Asia Pacific Human Papillomavirus Market Value (US$ Mn), by Disease Indication, 2018 & 2026 Figure 32: Asia Pacific Human Papillomavirus Market Value Share (%), by Disease Indication, 2018 Figure 33: Asia Pacific Human Papillomavirus Market Value (US$ Mn), by Distribution Channel, 2018 & 2026 Figure 34: Asia Pacific Human Papillomavirus Market Value Share (%), by Distribution Channel, 2018 Figure 35: Asia Pacific Human Papillomavirus Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026 Figure 36: Asia Pacific Human Papillomavirus Market Value Share (%), By Country/ Sub-region, 2018 Figure 37: Latin America Human Papillomavirus Market Value (US$ Mn), by Type, 2018 & 2026 Figure 38: Latin America Human Papillomavirus Market Value Share (%), by Type, 2018 Figure 39: Latin America Human Papillomavirus Market Value (US$ Mn), by Disease Indication, 2018 & 2026 Figure 40: Latin America Human Papillomavirus Market Value Share (%), by Disease Indication, 2018 Figure 41: Latin America Human Papillomavirus Market Value (US$ Mn), by Distribution Channel, 2018 & 2026 Figure 42: Latin America Human Papillomavirus Market Value Share (%), by Distribution Channel, 2018 Figure 43: Latin America Human Papillomavirus Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026 Figure 44: Latin America Human Papillomavirus Market Value Share (%), By Country/ Sub-region, 2018 Figure 45: Middle East & Africa Human Papillomavirus Market Value (US$ Mn), by Type, 2018 & 2026 Figure 46: Middle East & Africa Human Papillomavirus Market Value Share (%), by Type, 2018 Figure 47: Middle East & Africa Human Papillomavirus Market Value (US$ Mn), by Disease Indication, 2018 & 2026 Figure 48: Middle East & Africa Human Papillomavirus Market Value Share (%), by Disease Indication, 2018 Figure 49: Middle East & Africa Human Papillomavirus Market Value (US$ Mn), by Distribution Channel, 2018 & 2026 Figure 50: Middle East & Africa Human Papillomavirus Market Value Share (%), by Distribution Channel, 2018 Figure 51: Middle East & Africa Human Papillomavirus Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026 Figure 52: Middle East & Africa Human Papillomavirus Market Value Share (%), By Country/ Sub-region, 2018 Figure 53: Global Human Papillomavirus Market Share (%), By Company, 2018
GlaxoSmithKline plc. Merck & Co., Inc
  • PRICE
  • $4850
    $8850
    $6850
    Buy Now

Our Clients